Operating Lease, Right-of-Use Asset in USD of BIO-RAD LABORATORIES, INC. from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Bio Rad Laboratories, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • Bio Rad Laboratories, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $180M, a 3.7% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $180M +$6.43M +3.7% 30 Sep 2025 10-Q 29 Oct 2025
Q2 2025 $190M +$8.93M +4.92% 30 Jun 2025 10-Q 31 Jul 2025
Q1 2025 $153M -$35.7M -18.9% 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $161M -$34.2M -17.6% 31 Dec 2024 10-Q 29 Oct 2025
Q3 2024 $174M -$26.1M -13.1% 30 Sep 2024 10-Q 31 Oct 2024
Q2 2024 $181M +$7.55M +4.34% 30 Jun 2024 10-Q 02 Aug 2024
Q1 2024 $189M +$14.8M +8.51% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $195M +$13.7M +7.6% 31 Dec 2023 10-K 14 Feb 2025
Q3 2023 $200M +$28.4M +16.6% 30 Sep 2023 10-Q 27 Oct 2023
Q2 2023 $174M -$11.2M -6.06% 30 Jun 2023 10-Q 04 Aug 2023
Q1 2023 $174M -$24.4M -12.3% 31 Mar 2023 10-Q 05 May 2023
Q4 2022 $181M -$23.8M -11.6% 31 Dec 2022 10-K 16 Feb 2024
Q3 2022 $172M -$32.6M -16% 30 Sep 2022 10-Q 28 Oct 2022
Q2 2022 $185M -$5.08M -2.67% 30 Jun 2022 10-Q 29 Jul 2022
Q1 2022 $198M +$2.23M +1.14% 31 Mar 2022 10-Q 29 Apr 2022
Q4 2021 $205M +$2.66M +1.32% 31 Dec 2021 10-K 17 Feb 2023
Q3 2021 $204M +$7.54M +3.83% 30 Sep 2021 10-Q 29 Oct 2021
Q2 2021 $190M -$7.36M -3.72% 30 Jun 2021 10-Q 30 Jul 2021
Q1 2021 $196M -$4.26M -2.13% 31 Mar 2021 10-Q 30 Apr 2021
Q4 2020 $202M +$268K +0.13% 31 Dec 2020 10-K 11 Feb 2022
Q3 2020 $197M -$20.9M -9.59% 30 Sep 2020 10-Q 30 Oct 2020
Q2 2020 $198M -$17.9M -8.32% 30 Jun 2020 10-Q 31 Jul 2020
Q1 2020 $200M -$21.1M -9.53% 31 Mar 2020 10-Q 08 May 2020
Q4 2019 $202M +$202M 31 Dec 2019 10-K 16 Feb 2021
Q3 2019 $218M 30 Sep 2019 10-Q 01 Nov 2019
Q2 2019 $216M 30 Jun 2019 10-Q 06 Aug 2019
Q1 2019 $222M 31 Mar 2019 10-Q 10 May 2019
Q4 2018 $0 31 Dec 2018 10-K 02 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.